Elizabeth G. Ingram

Chief Executive Officer chez Cipla Therapeutics, Inc.

Profil

Elizabeth G.
Ingram is currently the President & Chief Executive Officer at Cipla Therapeutics, Inc. She previously served as an Independent Director at Avenue Therapeutics, Inc. from 2019 to 2022.
Prior to that, she was the Vice President-Market Access Strategy at Bristol Myers Squibb Co. from 2012 to 2014.
Elizabeth also held the position of Chief Marketing Officer at MannKind Corp.
in 2018 and was the Senior Vice President-Managed Market at DexCom, Inc. in 2017.
She completed her undergraduate degree at East Carolina University and her graduate degree at the University of South Carolina.

Postes actifs de Elizabeth G. Ingram

Sociétés	Poste	Début
Cipla Therapeutics, Inc.	Chief Executive Officer	-

Anciens postes connus de Elizabeth G. Ingram

Sociétés	Poste	Fin
AVENUE THERAPEUTICS, INC.	Director/Board Member	31/10/2022
MANNKIND CORPORATION	Sales & Marketing	01/06/2019
DEXCOM, INC.	Corporate Officer/Principal	01/12/2017
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/01/2014

Formation de Elizabeth G. Ingram

East Carolina University	Undergraduate Degree
University of South Carolina	Graduate Degree